James C. Edgemond's most recent trade in United Therapeutics Corp was a trade of 12,000 Stock Option done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 12,000 | 87,500 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 09 Jun 2025 | 12,000 | 20,118 (0%) | 0% | 117.8 | 1,413,120 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 325.20 per share. | 09 Jun 2025 | 7,700 | 8,418 (0%) | 0% | 325.2 | 2,504,068 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 325.44 per share. | 09 Jun 2025 | 3,595 | 16,523 (0%) | 0% | 325.4 | 1,169,955 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 326.56 per share. | 09 Jun 2025 | 305 | 16,218 (0%) | 0% | 326.6 | 99,602 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 326.81 per share. | 09 Jun 2025 | 300 | 8,118 (0%) | 0% | 326.8 | 98,042 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 328.28 per share. | 09 Jun 2025 | 100 | 16,118 (0%) | 0% | 328.3 | 32,828 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 02 Jun 2025 | 12,000 | 20,118 (0%) | 0% | 117.8 | 1,413,120 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 12,000 | 99,500 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 325.59 per share. | 02 Jun 2025 | 5,347 | 10,771 (0%) | 0% | 325.6 | 1,740,929 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 326.31 per share. | 02 Jun 2025 | 2,653 | 8,118 (0%) | 0% | 326.3 | 865,688 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 325.54 per share. | 02 Jun 2025 | 2,603 | 17,515 (0%) | 0% | 325.5 | 847,380 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 326.34 per share. | 02 Jun 2025 | 1,397 | 16,118 (0%) | 0% | 326.3 | 455,896 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2024 | 3,400 | 112,350 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 374.02 per share. | 04 Nov 2024 | 3,400 | 7,512 (0%) | 0% | 374.0 | 1,271,668 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 04 Nov 2024 | 3,400 | 10,912 (0%) | 0% | 117.8 | 400,384 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 04 Nov 2024 | 3,267 | 10,779 (0%) | 0% | 120.3 | 392,889 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2024 | 3,267 | 817 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 374.02 per share. | 04 Nov 2024 | 3,267 | 7,512 (0%) | 0% | 374.0 | 1,221,923 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2024 | 850 | 111,500 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 04 Nov 2024 | 850 | 8,633 (0%) | 0% | 117.8 | 100,096 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2024 | 817 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 04 Nov 2024 | 817 | 8,329 (0%) | 0% | 120.3 | 98,252 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 374.02 per share. | 04 Nov 2024 | 565 | 8,068 (0%) | 0% | 374.0 | 211,321 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 374.02 per share. | 04 Nov 2024 | 546 | 7,783 (0%) | 0% | 374.0 | 204,215 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 3,400 | 116,600 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 28 Oct 2024 | 3,400 | 10,378 (0%) | 0% | 117.8 | 400,384 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 28 Oct 2024 | 3,400 | 6,978 (0%) | 0% | 350 | 1,190,000 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 28 Oct 2024 | 3,267 | 10,245 (0%) | 0% | 120.3 | 392,889 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 28 Oct 2024 | 3,267 | 6,978 (0%) | 0% | 350 | 1,143,450 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 3,267 | 4,901 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 850 | 115,750 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 28 Oct 2024 | 850 | 8,088 (0%) | 0% | 117.8 | 100,096 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 817 | 4,084 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 28 Oct 2024 | 817 | 7,795 (0%) | 0% | 120.3 | 98,252 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 28 Oct 2024 | 576 | 7,512 (0%) | 0% | 350 | 201,600 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 28 Oct 2024 | 557 | 7,238 (0%) | 0% | 350 | 194,950 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 21 Oct 2024 | 3,400 | 9,826 (0%) | 0% | 117.8 | 400,384 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 366.99 per share. | 21 Oct 2024 | 3,400 | 6,426 (0%) | 0% | 367.0 | 1,247,766 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2024 | 3,400 | 120,850 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 366.99 per share. | 21 Oct 2024 | 3,267 | 6,426 (0%) | 0% | 367.0 | 1,198,956 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 21 Oct 2024 | 3,267 | 9,693 (0%) | 0% | 120.3 | 392,889 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2024 | 3,267 | 8,985 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2024 | 850 | 120,000 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 21 Oct 2024 | 850 | 7,545 (0%) | 0% | 117.8 | 100,096 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2024 | 817 | 8,168 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 21 Oct 2024 | 817 | 7,243 (0%) | 0% | 120.3 | 98,252 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 366.99 per share. | 21 Oct 2024 | 567 | 6,978 (0%) | 0% | 367.0 | 208,083 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 366.99 per share. | 21 Oct 2024 | 548 | 6,695 (0%) | 0% | 367.0 | 201,111 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 177.76 per share. | 14 Oct 2024 | 3,400 | 9,284 (0%) | 0% | 177.8 | 604,384 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 355.88 per share. | 14 Oct 2024 | 3,400 | 5,884 (0%) | 0% | 355.9 | 1,209,992 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2024 | 3,400 | 125,100 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 14 Oct 2024 | 3,267 | 9,151 (0%) | 0% | 120.3 | 392,889 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 355.88 per share. | 14 Oct 2024 | 3,267 | 5,884 (0%) | 0% | 355.9 | 1,162,660 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2024 | 3,267 | 13,069 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 14 Oct 2024 | 850 | 6,998 (0%) | 0% | 117.8 | 100,096 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2024 | 850 | 124,250 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 14 Oct 2024 | 817 | 6,701 (0%) | 0% | 120.3 | 98,252 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2024 | 817 | 12,252 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 355.88 per share. | 14 Oct 2024 | 572 | 6,426 (0%) | 0% | 355.9 | 203,563 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 355.88 per share. | 14 Oct 2024 | 553 | 6,148 (0%) | 0% | 355.9 | 196,802 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 3,400 | 129,350 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 355.54 per share. | 07 Oct 2024 | 3,400 | 5,344 (0%) | 0% | 355.5 | 1,208,836 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 07 Oct 2024 | 3,400 | 8,744 (0%) | 0% | 117.8 | 400,384 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 07 Oct 2024 | 3,267 | 8,611 (0%) | 0% | 120.3 | 392,889 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 3,267 | 17,153 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 355.54 per share. | 07 Oct 2024 | 3,267 | 5,344 (0%) | 0% | 355.5 | 1,161,549 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 850 | 128,500 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 07 Oct 2024 | 850 | 6,457 (0%) | 0% | 117.8 | 100,096 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 817 | 16,336 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 07 Oct 2024 | 817 | 6,161 (0%) | 0% | 120.3 | 98,252 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 355.54 per share. | 07 Oct 2024 | 573 | 5,884 (0%) | 0% | 355.5 | 203,724 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 355.54 per share. | 07 Oct 2024 | 554 | 5,607 (0%) | 0% | 355.5 | 196,969 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 3,400 | 133,600 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 358.62 per share. | 30 Sep 2024 | 3,400 | 4,802 (0%) | 0% | 358.6 | 1,219,308 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 30 Sep 2024 | 3,400 | 8,202 (0%) | 0% | 117.8 | 400,384 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 30 Sep 2024 | 3,267 | 8,069 (0%) | 0% | 120.3 | 392,889 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 3,267 | 21,237 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 358.62 per share. | 30 Sep 2024 | 3,267 | 4,802 (0%) | 0% | 358.6 | 1,171,612 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 850 | 132,750 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 30 Sep 2024 | 850 | 5,916 (0%) | 0% | 117.8 | 100,096 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 817 | 20,420 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 30 Sep 2024 | 817 | 5,619 (0%) | 0% | 120.3 | 98,252 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 358.62 per share. | 30 Sep 2024 | 572 | 5,344 (0%) | 0% | 358.6 | 205,131 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 358.62 per share. | 30 Sep 2024 | 553 | 5,066 (0%) | 0% | 358.6 | 198,317 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2024 | 3,400 | 137,850 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 354.04 per share. | 23 Sep 2024 | 3,400 | 4,264 (0%) | 0% | 354.0 | 1,203,736 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 23 Sep 2024 | 3,400 | 7,664 (0%) | 0% | 117.8 | 400,384 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 23 Sep 2024 | 3,267 | 7,531 (0%) | 0% | 120.3 | 392,889 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2024 | 3,267 | 25,321 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 354.04 per share. | 23 Sep 2024 | 3,267 | 4,264 (0%) | 0% | 354.0 | 1,156,649 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2024 | 850 | 137,000 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 23 Sep 2024 | 850 | 5,376 (0%) | 0% | 117.8 | 100,096 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2024 | 817 | 24,504 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.26 per share. | 23 Sep 2024 | 817 | 5,081 (0%) | 0% | 120.3 | 98,252 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 354.04 per share. | 23 Sep 2024 | 574 | 4,802 (0%) | 0% | 354.0 | 203,219 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 354.04 per share. | 23 Sep 2024 | 555 | 4,526 (0%) | 0% | 354.0 | 196,492 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 339.12 per share. | 16 Sep 2024 | 3,400 | 3,740 (0%) | 0% | 339.1 | 1,153,008 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 16 Sep 2024 | 3,400 | 7,140 (0%) | 0% | 117.8 | 400,384 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 3,400 | 142,100 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 339.12 per share. | 16 Sep 2024 | 3,267 | 3,740 (0%) | 0% | 339.1 | 1,107,905 | Common Stock |